pyridoxine has been researched along with oxymetholone in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (40.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Boxer, LA; Clarke, TL; Hussey, L | 1 |
Lukens, JN; Neuman, LA | 1 |
Han, DH; Hong, DS; Ji, YS; Kim, CK; Kim, HJ; Kim, HK; Kim, KH; Kim, SH; Lee, KT; Lee, MS; Min, CW; Park, SK; Won, JH; Yun, J | 1 |
1 review(s) available for pyridoxine and oxymetholone
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 other study(ies) available for pyridoxine and oxymetholone
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Sideroblastic anemia following congenital erythroid hypoplasia.
Topics: Anemia, Aplastic; Anemia, Sideroblastic; Blood Transfusion; Humans; Infant; Iron; Male; Methyltestosterone; Oxymetholone; Porphyrins; Prednisone; Pyridoxine | 1971 |
EXcretion and distribution of iron during chronic deferoxamine therapy.
Topics: Anemia, Aplastic; Bone Marrow; Bone Marrow Examination; Child; Chromium Isotopes; Deferoxamine; Folic Acid; Heart Failure; Hemosiderosis; Humans; Iron; Iron Chelating Agents; Liver; Male; Mononuclear Phagocyte System; Oxymetholone; Prednisone; Pyridoxine; Spleen; Splenectomy; Tissue Extracts; Transfusion Reaction; Vitamin B 12 | 1971 |
Biomarkers of angiogenesis as prognostic factors in myelodysplastic syndrome patients treated with hypomethylating agents.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Bone Marrow Examination; Humans; Immunosuppressive Agents; Microvessels; Middle Aged; Myelodysplastic Syndromes; Neovascularization, Pathologic; Oxymetholone; Prognosis; Pyridoxine; Retrospective Studies; Survival Rate; Vascular Endothelial Growth Factor A; Young Adult | 2016 |